These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 14496233)

  • 1. [Clinical study of cerebrospinal fluid in neuropsychiatric patients: glycoprotein, especially in refer to protein-bound polysaccharide hexose (PBP)].
    SAKURADA S
    Seishin Shinkeigaku Zasshi; 1962 Mar; 64():324-50. PubMed ID: 14496233
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the protein-bound polysaccharide hexone (PBP) of the cerebrospinal fluid in neuropsychiatric field. Part II. Survey in epilepsy, manic-depressive and other psychosis cases.
    SAKURADA S; TANAKA Z; TAKASE M
    Folia Psychiatr Neurol Jpn; 1960 Apr; 14():71-80. PubMed ID: 13745511
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on protein-bound polysaccharide hexose (PBP) of the cerebrospinal fluid in neuropsychiatric fields. Part I. Method for quantitative measurement and survey in normal subjects and schizophrenic patients.
    SAKURADA S; TANAKA Z; SAKURADA T
    Folia Psychiatr Neurol Jpn; 1960 Apr; 14():59-70. PubMed ID: 13745509
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the total protein-bound polysaccharide hexose (PBP) of cerebrospinal fluid in the neuropsychiatric field. III. Survey in general paresis, brain tumor and other diseases of central nervous system.
    SAKURADA S; TANAKA Z; SAKURADA T
    Folia Psychiatr Neurol Jpn; 1960 Jul; 14():167-77. PubMed ID: 13745510
    [No Abstract]   [Full Text] [Related]  

  • 5. [Glycoproteins in the cerebrospinal fluid. VI. Glycoproteins in the cerebrospinal fluid in mental diseases].
    LANG BA; BROUCKOVA V; BLATAK F
    Acta Biol Med Ger; 1961; 7():96-105. PubMed ID: 14462034
    [No Abstract]   [Full Text] [Related]  

  • 6. [Research on the cerebrospinal fluid trypsin inhibitor in neurological and psychiatric patients].
    CANAL N; FRATTOLA L
    Boll Soc Ital Biol Sper; 1961 Jun; 37():496-8. PubMed ID: 13690354
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification and quantification of proteins, glycoproteins and lipoproteins of cerebrospinal fluid.
    GOLDSTEIN NP; HILL NC; McKENZIE BF; McGUCKIN WF; SVIEN HJ
    Med Clin North Am; 1960 Jul; 44():1053-74. PubMed ID: 13850791
    [No Abstract]   [Full Text] [Related]  

  • 8. Fractionation and quantitative analysis of cerebrospinal fluid constituents with reference to neuropsychiatric disorders.
    BOGOCH S
    Am J Psychiatry; 1958 May; 114(11):1028-9. PubMed ID: 13533632
    [No Abstract]   [Full Text] [Related]  

  • 9. [Blood content and sugar level in the cerebrospinal fluid].
    TOMASZEWSKI L; KOZIEROWSKA T
    Pol Tyg Lek; 1961 Feb; 16():285-7. PubMed ID: 13777303
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on cerebrospinal fluid. I. Quantitative fractionation of carbohydrate constituents.
    BOGOCH S
    J Biol Chem; 1960 Jan; 235():16-22. PubMed ID: 13802140
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunochemical measurement of gamma globulins in the cerebrospinal fluid in mental disorders].
    DELAY J; MOLLARET P; BURTIN P; LEMPERIERE T
    Ann Med Psychol (Paris); 1956 May; 114(5):834-9; discussion, 840. PubMed ID: 13340362
    [No Abstract]   [Full Text] [Related]  

  • 12. Prefractionation of cerebrospinal fluid to enhance glycoprotein concentration prior to structural determination with FT-ICR mass spectrometry.
    Sihlbom C; Davidsson P; Nilsson CL
    J Proteome Res; 2005; 4(6):2294-301. PubMed ID: 16335978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and determination of the glycoproteins in cerebrospinal fluid.
    ROBOZ E; MURPHY JB; HESS WC; FORSTER FM
    Proc Soc Exp Biol Med; 1955 Aug; 89(4):691-4. PubMed ID: 13254868
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study of determination of sedimentation rate in cerebrospinal fluid and its clinical significance in neuro-psychiatry].
    D'ALBA A
    Minerva Med; 1955 Aug; 46(69):436-7. PubMed ID: 13265314
    [No Abstract]   [Full Text] [Related]  

  • 15. CEREBROSPINAL FLUID TOTAL POLYSACCHARIDE IN DISEASES OF THE NERVOUS SYSTEM.
    MANNO NJ; MCGUCKIN WF; GOLDSTEIN NP
    Neurology; 1965 Jan; 15():49-55. PubMed ID: 14257827
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical experiences with electrophoretic study of CSF proteins].
    DELANK HW
    Dtsch Z Nervenheilkd; 1956; 174(5):429-42. PubMed ID: 13344110
    [No Abstract]   [Full Text] [Related]  

  • 17. [Importance of cerebrospinal fluid diagnostics in neuropsychiatric diseases].
    Tumani H; Uhr M; Wildemann B; Wick M
    Nervenarzt; 2016 Dec; 87(12):1259-1260. PubMed ID: 27853851
    [No Abstract]   [Full Text] [Related]  

  • 18. [Organic psychosyndrome and cerebrospinal fluid].
    BLEULER M
    Pract Otorhinolaryngol (Basel); 1948; 10(1-2):156-61. PubMed ID: 18908758
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chromatographic studies of the amino acids of the cerebrospinal fluid in mental disorders].
    MAGHERINI G
    Rass Studi Psichiatr; 1954; 43(1):26-32. PubMed ID: 13167478
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on the protein-bound carbohydrates and lipids in the cerebrospinal fluid].
    FRICK E
    Dtsch Z Nervenheilkd; 1962; 184():53-70. PubMed ID: 13959694
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.